Soranib 200

Soranib 200mg Tablet is part of the anti-cancer medication category. It contains the active component Sorafenib, which is used for treating advanced renal cell carcinoma (kidney cancer), advanced hepatocellular carcinoma (liver cancer) in patients who cannot undergo surgery, and differentiated thyroid carcinoma (thyroid cancer) in patients who do not respond to radioactive iodine therapy.

Common side effects associated with Soranib 200mg Tablet include diarrhea, fatigue, abdominal pain, nausea, weakness, skin rashes, flu-like symptoms, loss of appetite, weight reduction, and low calcium levels in the blood. If any of these side effects are bothersome or persist, please inform your doctor.

Notify your doctor if you have an allergy to this Tablet or any of its components. Prior to commencing treatment with this tablet, it is important to inform your physician if you have a history of heart issues, chest pain, bleeding disorders, high blood pressure, or if you have had or are planning to have surgery. Women should use effective contraception during treatment and for 6 months after the final dose, while men should do so for 3 months after their last dose.